Detection and structural characterization of ras oncoprotein-inhibitors complexes by electrospray mass spectrometry
Abstract
MS based methodology employing electrospray ionization (ESI) is described for the detection of ternary complexes in which SCH 54292 or SCH 54341 and GDP are noncovalently bound to oncogenic ras protein. The observed molecular weights of 19,816 and 19,570 Da confirmed the presence of noncovalent complexes of ras-GDP-SCH 54292 and ras-GDP-SCH 54341, respectively. We have also performed selective chemical modification of lysine residues of the ras protein complex followed by enzymatic digestion and on-line LC-ESI MS peptide mapping to determine protein-drug binding topography. There was a good correlation between nucleotide exchange inhibition as determined by the enzyme assay and evidence of complex formation as determined by MS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SCH-54292 was designed to suppress formation of active GTP-bound Ras by binding to a cleft close to switch II on Ras protein.
“For example, SCH-54292 (6) was designed to suppress the formation of active GTP-bound Ras by binding to a cleft close to switch II on Ras protein.46”
From Overcoming Resistance to Drugs Targeting KRAS Mutation (2020) · cites this paper as [46]
Cites
PAI, E. F., Krengel, U., Petsko, G. A., Goody, R. S., Kabsch, W., & Wittinghofer, A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07409.x · Cited by 1,074 · see citing works
The Cellular Functions of Small GTP-Binding Proteins
Hall, A. (1990) · Science · doi:10.1126/science.2116664 · Cited by 866 · see citing works
ras GTPase activating protein: Signal transmitter and signal terminator
McCormick, F. (1989) · Cell · doi:10.1016/0092-8674(89)90976-8 · Cited by 607 · see citing works
Detection of noncovalent receptor-ligand complexes by mass spectrometry
Ganem, B., Li, Y., & Henion, J. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00016a069 · Cited by 464 · see citing works
Ganem, B., Li, Y. T., & Henion, J. D. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00020a085 · Cited by 331 · see citing works
ras oncogenes: their role in neoplasia
Barbacid, M. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01848.x · Cited by 242 · see citing works
Observation of a small oligonucleotide duplex by electrospray ionization mass spectrometry
Light‐Wahl, K. J., Springer, D. L., Winger, B. E., Edmonds, C. G., Camp, D., Thrall, B. D., & Smith, R. D. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00055a070 · Cited by 158 · see citing works
Baca, M., & Kent, S. B. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00036a066 · Cited by 146 · see citing works
Taveras, A. G., Remiszewski, S., Doll, R. J., Cesarz, D., Huang, E. C., Kirschmeier, P. T., Pramanik, B. N., Snow, M. E., Wang, Y.-S., del Rosario, J., et al. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(96)00202-7 · Cited by 123 · see citing works
Self-citationGanguly, A. K., Pramanik, B. N., Tsarbopoulos, A., Covey, T. R., Huang, E. C., & Fuhrman, S. A. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00042a046 · Cited by 100 · see citing works
Self-citationHuang, E. C., Pramanik, B. N., Tsarbopoulos, A., Reichert, P., Ganguly, A. K., Trotta, P. P., Nagabhushan, T. L., & Covey, T. R. (1993) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(93)85026-t · Cited by 58 · see citing works
Self-citationSteiner, R. F., Albaugh, S., Fenselau, C., Murphy, C. M., & Vestling, M. M. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90127-f · Cited by 42 · see citing works
Studies of the Ras-GDP and Ras-GTP noncovalent complexes by electrospray mass spectrometry
Ganguly, A. K., Pramanik, B. N., Huang, E. C., Tsarbopoulos, A., GIRIJAVALLABHAN, V. M., & Liberles, S. D. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)88022-4 · Cited by 26 · see citing works
Self-citationTsarbopoulos, A., Pramanik, B. N., Nagabhushan, T. L., & Covey, T. R. (1995) · Journal of Mass Spectrometry · doi:10.1002/jms.1190301217 · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Ostrem, J. M. L., & Shokat, K. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.139 · Cited by 641 · see citing works
Maurer, T., Garrenton, L. S., Oh, A., Pitts, K., Anderson, D. J., Skelton, N. J., Fauber, B. P., Pan, B., Malek, S., Stokoe, D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116510109 · Cited by 618 · see citing works
Burlingame, A. L., Boyd, R. K., & Gaskell, S. J. (1998) · Analytical Chemistry · doi:10.1021/a1980023+ · Cited by 148 · see citing works
Weiss, A., Lorthiois, E., Barys, L., Beyer, K. S., Bomio-Confaglia, C., Burks, H., Chen, X., Cui, X., de Kanter, R., Dharmarajan, L., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0158 · Cited by 150 · see citing works
Ras inhibition via direct Ras binding—is there a path forward?
Wang, W., Fang, G., & Rudolph, J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.082 · Cited by 104 · see citing works
Direct Modulation of Small GTPase Activity and Function
Cromm, P. M., Spiegel, J., Grossmann, T. N., & Waldmann, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504357 · Cited by 78 · see citing works
Inhibitors of Ras–SOS Interactions
Lu, S., Jang, H., Zhang, J., & Nussinov, R. (2016) · ChemMedChem · doi:10.1002/cmdc.201500481 · Cited by 72 · see citing works
Inhibition of Ras–effector interactions by cyclic peptides
Wú, X., Upadhyaya, P., Villalona-Calero, M. A., Briesewitz, R., & Pei, D. (2012) · MedChemComm · doi:10.1039/c2md20329d · Cited by 69 · see citing works
Reyzer, M. L. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.21.e103 · Cited by 69 · see citing works
Progress in targeting RAS with small molecule drugs
McCormick, F. P. (2019) · Biochemical Journal · doi:10.1042/bcj20170441 · Cited by 63 · see citing works
Overcoming Resistance to Drugs Targeting KRAS Mutation
Jiao, D., & Yang, S. (2020) · The Innovation · doi:10.1016/j.xinn.2020.100035 · Cited by 61 · see citing works
Design, Synthesis and Biological Evaluation of Sugar‐Derived Ras Inhibitors
Peri, F., Airoldi, C., Colombo, S., Martegani, E., van Neuren, A. S., Stein, M., Marinzi, C., & Nicotra, F. (2005) · ChemBioChem · doi:10.1002/cbic.200400420 · Cited by 41 · see citing works
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D
Palmioli, A., Sacco, E., Airoldi, C., Nicolantonio, F. D., D’Urzo, A., Shirasawa, S., Sasazuki, T., Domizio, A. D., GIOIA, L. D., Martegani, E., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.069 · Cited by 33 · see citing works
The centaurin γ-1 GTPase-like domain functions as an NTPase
Soundararajan, M., Yang, X., Elkins, J. M., Sobott, F., & Doyle, D. (2007) · Biochemical Journal · doi:10.1042/bj20060555 · Cited by 29 · see citing works
Zhang, Y., Wang, Z., Ma, X., Yang, S., Hu, X., Tao, J., Hou, Y., & Bai, G. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.002 · Cited by 25 · see citing works
Direct GDP-KRAS G12C inhibitors and mechanisms of resistance: the tip of the iceberg
Rosen, J. C., Sacher, A. G., & Tsao, M. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231160141 · Cited by 22 · see citing works
Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities
Zhang, J., Park, D., Shin, D. M., & Deng, X. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv118 · Cited by 19 · see citing works
Ganaie, A. A., Siddique, H. R., SHEIKH, I. A., Parray, A., Wang, L., Panyam, J., Villalta, P. W., Deng, Y., Konety, B. R., & Saleem, M. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23200 · Cited by 17 · see citing works
Prinz, H., Lavie, A., Scheidig, A. J., Spangenberg, O., & Konrad, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35337 · Cited by 17 · see citing works
Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families
Li, L., Meyer, C., Zhou, Z.-W., Elmezayen, A., & Westover, K. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167626 · Cited by 14 · see citing works
Determination of micelle mass by electrospray ionization mass spectrometry
Nohara, D., Kajiura, T., & Takeda, K. (2005) · Journal of Mass Spectrometry · doi:10.1002/jms.818 · Cited by 14 · see citing works
Direkte Modulation von Aktivität und Funktion kleiner GTPasen
Cromm, P. M., Spiegel, J., Grossmann, T. N., & Waldmann, H. (2015) · Angewandte Chemie · doi:10.1002/ange.201504357 · Cited by 9 · see citing works
NMR Study to Identify a Ligand-Binding Pocket in Ras
Maurer, T., & Wang, W. (2013) · The Enzymes · doi:10.1016/b978-0-12-416749-0.00002-6 · Cited by 9 · see citing works
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors
Colombo, S., Palmioli, A., Airoldi, C., Tisi, R., Fantinato, S., Olivieri, S., GIOIA, L. D., Martegani, E., & Peri, F. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791054185 · Cited by 9 · see citing works
Li, N., Liu, C., Zhang, W., & Rao, G. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673258913231019113814 · Cited by 7 · see citing works
Spiclomazine displays a preferential anti-tumor activity in mutant KRas-driven pancreatic cancer
Guo, X., Zhao, W., Liu, Z., & Wang, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24025 · Cited by 7 · see citing works
Sugar-Based Inhibitors of Ras Activation
Domizio, A. D., & Peri, F. (2013) · The Enzymes · doi:10.1016/b978-0-12-416749-0.00005-1 · Cited by 2 · see citing works
Liu, Y., Ramanathan, L., Malcolm, B. A., Njoroge, G. F., Chan, T., & Pramanik, B. N. (2011) · Journal of Mass Spectrometry · doi:10.1002/jms.1948 · Cited by 2 · see citing works
Self-citationPromising Molecular Targets for Design of Antitumor Drugs Based on Ras Protein Signaling Cascades
Klochkov, S. G., Евгеньевна, Н. М., & Aleksandrova, Y. R. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162020050118 · Cited by 2 · see citing works
Mechanism of Action and Metabolism of Antineoplastic and Chemopreventive Agents
(2002) · CRC Press eBooks · doi:10.1201/9781420042696.ch5
BindingDB Entry 50042134: Ras inhibition via direct Ras binding--is there a path forward?
BindingDB (2013) · UC San Diego · doi:10.7270/q2rr20jz
- Authors
- Ganguly, A. K., Pramanik, B. N., Huang, E. C., Liberles, S., Heimark, L., Liu, Y. H., Tsarbopoulos, A., Doll, R. J., Taveras, A. G., Remiszewski, S., Snow, M. E., Wang, Y. S., Vibulbhan, B., Cesarz, D., Brown, J. E., del Rosario, J., James, L., Kirschmeier, P., & Girijavallabhan, V.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-05
- Volume
- 5
- Issue
- 5
- Pages
- 817-820
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2003988185
- Cited by
- 31
- References
- 14
- Citations by year
- 2023: 2 · 2022: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 4 · 2013: 2 · 2012: 3
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- GDP binding, peptide mapping
- MeSH terms
- Amino Acid Sequence, Antineoplastic Agents, Binding Sites, Drug Evaluation, Preclinical, Glucosides, Molecular Sequence Data, Molecular Weight, Peptide Mapping, Proteins, Mass Spectrometry, Sulfonamides, ras Proteins, Guanine Nucleotide Exchange Factors, ras Guanine Nucleotide Exchange Factors, Macromolecular Substances, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review